ライフサイエンスコーパス: BED

1 BED and PG are thus dissociable as a function of dopamin

2 BED as a continuous variable significantly affected LC (

3 BED is commonly associated with obesity and with somatic

4 BED subjects showed widespread reductions in [(11)C]carf

5 BED testing demonstrated high reproducibility among all

6 BED-FRAME demonstrated that each RDT had utility at diff

7 BED-FRAME evaluates diagnostic yield and addresses 2 key

8 BED-FRAME is a useful fundamental supplement to the stan

9 BED-FRAME is a useful tool that can used to determine wh

10 BED-FRAME provides a tool for communicating the expected

11 The HIV-1 BED incidence assay was developed at the Centers for Dis

12 robands with (n = 150) and without (n = 150) BED, and their first-degree relatives (n = 888) in a com

13 dose distributions were used to generate 3D BED distributions.

14 y and the inbreeding status of 35 SED and 49 BED with limited pedigree information.

15 Thirty-nine participants (15 PG, 7 BED, and 17 controls) were scanned with [(11)C]carfentan

16 A BED greater than 80.5 Gy seems to be an ablative dose of

17 A BED-specific proficiency testing (PT) program was initia

18 rate was significantly higher (78%) after a BED greater than 80.5 Gy than after lower doses (45%, P

19 ore, which suggests a possible origin from a BED finger-like intermediate that was in turn ultimately

20 large and short centromeres and generates a BED file indicating the location of the CDRs within the

21 Results are exported in a BED format for rapid visualization in the UCSC genome br

22 o features were selected after delivery of a BED 40 Gy, with an AUC = 0.716 (0.600-0.786).

23 gical parameters for (90)Y were applied to a BED model, providing a calculation method that has the p

24 incarceration, we tested their sera using a BED HIV-1 capture enzyme immunoassay to estimate HIV inc

25 he effects of group CBT and group IPT across BED-related symptoms among overweight individuals with B

26 exia nervosa and bulimia nervosa, and adding BED as a specified eating disorder.

27 ture onset of BN and PD but not onset of AN, BED, or any eating disorder, and baseline current weight

28 The AD and BED metrics yielding 50% TCP were 292 and 441 Gy, respec

29 This study examined the prevalence of BN and BED among active-duty service members and identified mil

30 ly associated with increased risk for BN and BED included active-duty component (vs.

31 y, temporal associations between EDs (BN and BED) and mental health conditions (posttraumatic stress

32 oss-lagged associations varied across BN and BED.

33 Role impairments are similar for BN and BED.

34 tides encompassing the proximal, distal, and BED/AP-1-binding regions failed to demonstrate selective

35 ad WB (0.90); within 60 days, the LS-EIA and BED (both 0.85); and for persons within 90 days the BED

36 lly customizable, with a choice of FASTA and BED output formats.

37 cing transcript structures from GFF/GFF3 and BED files.

38 ivities, time-to-results, hands-on time, and BED-FRAME analysis.

39 scribe a set of "stratifications," which are BED files that define distinct contexts throughout the g

40 wo genomic intervals, usually represented as BED files, are located in the same genomic regions.

41 n regulatory DNA sequences are visualized as BED-based annotation tracks, which highlight the genomic

42 ced by most RNA-seq mapping tools as well as BED files, which are widely used for gene models.

43 The microarray data and associated .BED and .WIG files can be accessed through Gene Expressi

44 We identify shared heritability between BED and several neuropsychiatric traits, and implicate i

45 inc fingers 1 to 3 are potential DNA-binding BED finger domains recently proposed to play a role in a

46 ght) correlates with future onset of AN, BN, BED, and PD.

47 of sequence alignments in BAM format to both BED and GFF features.

48 ded data set of 1354 specimens classified by BED, the optimized MBC performed significantly better th

49 developed an immunoglobulin G (IgG)-capture BED-enzyme immunoassay (BED-CEIA) to identify recent hum

50 ine-rich repeat (NLR) protein featuring a CC-BED module formed by a zinc finger BED (Znf-BED) domain

51 participated in a 5-day bed rest challenge (BED REST).

52 genomic features in Browser Extensible Data (BED) and General Feature Format (GFF) format.

53 a formats including Browser Extensible Data (BED), bedGraph and Browser Extensible Data Paired-End (B

54 of a male SED and a male Burmese Eld's deer (BED), and used genome-wide single nucleotide polymorphis

55 tirely to BN and to a somewhat lesser degree BED predicting subsequent onset of these conditions.

56 sorders (EDs) such as binge eating disorder (BED) and bulimia nervosa (BN) among military personnel,

57 ostic overlap between binge eating disorder (BED) and substance use disorders (SUDs), including loss

58 imia nervosa (BN) and binge eating disorder (BED) are prevalent in military populations, an understan

59 imia nervosa (BN) and binge eating disorder (BED) are the most prevalent eating disorders (EDs) among

60 Binge-eating disorder (BED) is a prevalent, costly public health problem associ

61 Binge eating disorder (BED) is a public health concern that has received little

62 Binge-eating disorder (BED) is characterized by recurring episodes of excessive

63 Binge eating disorder (BED) is characterized by regular binge eating episodes d

64 Binge eating disorder (BED) is one of the most frequent eating pathologies and

65 Binge eating disorder (BED) is the most common eating disorder, yet its genetic

66 who met criteria for Binge Eating Disorder (BED) or subthreshold BED, had a body mass index (BMI; ca

67 ifetime prevalence of binge eating disorder (BED) was 2%.

68 e (LDX) vs placebo in binge eating disorder (BED) was evaluated in two multicenter, double-blind, pla

69 seeking treatment for binge eating disorder (BED) were compared with 19 non-BED obese individuals (OB

70 and without (n = 30) binge eating disorder (BED) were compared with matched healthy volunteers and t

71 Binge-eating disorder (BED), a public health problem associated with psychopath

72 bulimia nervosa (BN), binge eating disorder (BED), and purging disorder (PD).

73 dard for treatment of binge eating disorder (BED), most individuals do not have access to this specia

74 bulimia nervosa (BN), binge eating disorder (BED), other specified feeding and eating disorders (OSFE

75 se disorders (AUD) or binge-eating disorder (BED), suggest a disturbance in explore-exploit decision-

76 Binge-eating disorder (BED)-a syndrome that only recently has attracted scienti

77 ecialty treatment for binge eating disorder (BED).

78 for the treatment of binge eating disorder (BED).

79 in patients with the binge eating disorder (BED).

80 cal gambling (PG) and binge eating disorder (BED).

81 n the epidemiology of binge eating disorder (BED).

82 mia nervosa (BN), and binge eating disorder (BED)].

83 Women with binge-eating disorder (BED; n = 38) and age- and weight-matched women without B

84 d disorders somewhat more strongly than does BED.

85 ximal tolerated biologically effective dose (BED(max)) for organs at risk (OARs) in the treatment of

86 d calculating tumor biologic effective dose (BED) along the normal-organ MTBED limits, we obtained th

87 c effects using biologically effective dose (BED) and equivalent uniform dose (EUD) was developed in

88 s) were used in biologically effective dose (BED) calculations.

89 ose (AD) metrics, biological effective dose (BED) metrics, equivalent uniform dose, and equivalent un

90 Biologically effective dose (BED) thresholds for the formation of FLRs were calculate

91 stribution by a biologically effective dose (BED) volume histogram (BVH).

92 and calculated biologically effective dose (BED) with radionuclide-induced nephrotoxicity.

93 o calculate the biologically effective dose (BED).

94 tions for a median biologic equivalent dose (BED) of 80.5 Gy (range, 43.75 to 180 Gy).

95 after delivered biological effective doses (BED, alpha/beta = 10) of 20 Gy and 40 Gy.

96 Users submit a bedpe (paired-end BED format) file containing the locations and strengths

97 n which Hermes multimerizes to gather enough BED domains to find its left-end among the abundant geno

98 ation sequencing experiments, such as FASTQ, BED and BAM format files.

99 de array of file formats (e.g. FASTA, FASTQ, BED, BEDPE, SAM, BAM, and VCF), and can convert and inte

100 no relation to more than 10 purebred female BED were identified.

101 ChromoMap takes tab-delimited files (BED like) or alternatively R objects to specify the geno

102 Finally, BED distributions were used to estimate an EUD for each

103 ring a CC-BED module formed by a zinc finger BED (Znf-BED) domain integrated into the coiled-coil (CC

104 discovered transcription factor, zinc finger BED domain-containing protein 6 (ZBED6), is expressed in

105 Zinc finger, BED-type containing 6 (ZBED6) is an important transcript

106 The transcription factor ZBED6 (zinc finger, BED-type containing 6) is a repressor of IGF2 whose acti

107 We use assays for BED, avidity, viral load, and CD4 cell count data from c

108 based treatments are currently available for BED.

109 65 years who met the diagnostic criteria for BED (according to the Diagnostic and Statistical Manual

110 female [96.10%]) fulfilled the criteria for BED and were randomized (77 each to the intervention and

111 rweight patients meeting DSM-IV criteria for BED were randomly assigned to 20 weekly sessions of eith

112 d pharmacological interventions, and DBT for BED; and CBT and psychodynamic therapy for OSFED.

113 than men, and no sex difference emerged for BED onset.

114 11 genes and suggest APOE as a risk gene for BED.

115 tly (median; interquartile range) higher for BED (1.4%; .8-1.9%) than BN (.8%; .4-1.0%).

116 xamfetamine (LDX), and combined CBT+LDX, for BED comorbid with obesity.

117 utcome, including mortality, are limited for BED.

118 eterans from the Millennium Cohort Study for BED and BN analyses, respectively.

119 sychotherapy is the first-line treatment for BED.

120 and to save the output in different formats (BED, Wig or counts).

121 Risk Evaluation of Diagnostics: A Framework (BED-FRAME) is a strategy for pragmatic evaluation of dia

122 using the Benefit-risk Evaluation Framework (BED-FRAME) analysis.

123 files in TAB-delimited formats such as GFF, BED, PSL, SAM and SQL export, and quickly retrieves feat

124 ensive output for identified peaks with GFF, BED, bedGraph and .wig formats, annotated genes to which

125 For elite suppressors, 10/18 had BED-CEIA values <0.8 normalized optical density units (O

126 For patients receiving ART, 14/18 had BED-CEIA values that decreased over time, with a median

127 te the probability of each individual having BED based on electronic medical records from the Million

128 ulin G (IgG)-capture BED-enzyme immunoassay (BED-CEIA) to identify recent human immunodeficiency viru

129 ted with the BED capture enzyme immunoassay (BED-CEIA) which measures the proportion of IgG that is H

130 includes the BED capture enzyme immunoassay (BED-CEIA), an antibody avidity assay, HIV load, and CD4(

131 includes the BED capture enzyme immunoassay (BED-CEIA), the Bio-Rad Avidity assay, viral load, and CD

132 ightened incidence of sleep abnormalities in BED.

133 breakthrough were associated with changes in BED-CEIA values, reflecting changes in the proportion of

134 compulsive eating and sleep dysregulation in BED, and provide a comprehensive update on the evidence

135 simple interface to upload an input file in BED format and customize parameters for each task.

136 d CBT+LDX showed significant improvements in BED, with a consistent pattern of the combined CBT+LDX b

137 in regional activation were investigated in BED, OB, and LC groups during reward/loss prospect, anti

138 Further investigation of lisdexamfetamine in BED is ongoing.

139 er and [(18)F]fluorodopa Ki was 20% lower in BED compared with PG and controls (p<0.002).

140 tion of viral recombination data provided in BED format generated by computational pipelines such as

141 rich repeat (NLR) protein with an integrated BED domain.

142 effective doses (BEDs) for a maximal kidney BED (20 Gy2.5) for different peptide amounts and activit

143 The red marrow and the kidneys (BED(max) of 2 Gy(15) and 40 Gy(2.5), respectively) were

144 The median for the lesion BED from RPT and SBRT was 159 Gy (range, 124-219 Gy).

145 on to any female SED and three purebred male BED with no relation to more than 10 purebred female BED

146 e tool and a python library that manipulates BED files of possibly irregularly spaced P-values and (1

147 ng the additional constraint of a red marrow BED less than 1 Gy15, was individually quantified.

148 contributed approximately 40% to the maximum BED from RPT and SBRT.

149 Median BED threshold values for FLR development were 63.6 Gy at

150 ills of military spouses, which may mitigate BED symptoms stemming from military-related stressors (e

151 ith its transposon left-end through multiple BED domains of three Hermes protomers contributed by thr

152 Cross-national BED data are presented here and compared with bulimia ne

153 ith a set of new and updated features: a new BED import functionality for the workbench, improved int

154 By contrast, the right-end is bound to no BED domains at all.

155 ing disorder (BED) were compared with 19 non-BED obese individuals (OB) and 19 lean control subjects

156 , for the purposes of exposition, nonuniform BED distributions are represented by normal distribution

157 rder (OR: 1.32; 95% CI: 1.12, 1.56), but not BED (OR: 1.10; 95% CI: 0.89, 1.37).

158 ndicates that OSU6162 might serve as a novel BED medication.

159 The aetiology of BED is complex, including genetic and environmental fact

160 op two features identified after delivery of BED 20 Gy were gray level co-occurrence matrix features

161 (90)Y SIRT and EBRT, leading to inflation of BED for SIRT and possible undertreatment.

162 o have utility in the clinical management of BED.

163 eeded to understand underlying mechanisms of BED and to improve prevention and treatment outcomes for

164 tle is known about the course and outcome of BED in the community.

165 his may contribute to the pathophysiology of BED.

166 te iron metabolism in the pathophysiology of BED.

167 Three patterns of BED-CEIA values were observed during viral breakthrough:

168 The worldwide prevalence of BED for the years 2018-2020 is estimated to be 0.6-1.8%

169 Follow-up studies of BED are scarce; remission rates in randomized controlled

170 fficacy for the core and related symptoms of BED.

171 baseline data for the successful transfer of BED-CEIA to other laboratories and the use of BED-CEIA f

172 ED-CEIA to other laboratories and the use of BED-CEIA for the detection of recent HIV seroconversion

173 ent maximizing the number of cycles based on BED(max) for red marrow and kidneys, and a treatment hav

174 Recognition and research on BED has increased since its inclusion into DSM-5; howeve

175 d with the development of BN (n = 96 245) or BED (n = 113 733).

176 Fewer than half of lifetime BN or BED cases receive treatment.

177 accepts input sequences in either FASTA- or BED-formatted data files.

178 ts long-term impact and time course on other BED-related symptoms remain largely unknown.

179 g files) or functional genomic regions (peak/BED files).

180 We present Bedshift, a tool for perturbing BED files by randomly shifting, adding, and dropping reg

181 Compared with PG, BED patients show widespread losses of mu-opioid recepto

182 ons among sex, race, ethnicity, and probable BED and BN onset.

183 ctors and a follow-up assessment of probable BED approximately 3 years later.

184 ormer smokers had increased risk of probable BED at follow-up.

185 udinal study examined predictors of probable BED in a sample of US military spouses (n = 5269).

186 had not deployed had higher risk of probable BED than spouses whose service member deployed without c

187 The 3-year OS rate for patients receiving BED greater than 80.5 Gy was 73% versus 38% for those re

188 vealed a second functional YY1 binding site (BED) that overlaps with an AP1 binding site.

189 ed SED genetic material was observed in some BED individuals.

190 Studying BED is challenging because it is often comorbid with obe

191 compared with each other or to AUD subjects, BED had enhanced exploratory behaviors particularly in t

192 ts of mental health conditions on subsequent BED were significantly stronger than BED to mental healt

193 adult outpatients with full or subsyndromal BED were recruited from 7 university-based outpatient cl

194 Binge Eating Disorder (BED) or subthreshold BED, had a body mass index (BMI; calculated as weight in

195 tly higher for BN (6.5 years; 2.2-15.4) than BED (4.3 years; 1.0-11.7).

196 sequent BED were significantly stronger than BED to mental health condition cross-lagged effects.

197 uent onset of BN somewhat more strongly than BED and that BN predicts subsequent comorbid disorders s

198 ven to an additional behavioral symptom that BED shares with SUDs-sleep dysregulation-and the extent

199 itive (LS) enzyme immunoassay (EIA), and the BED assay.

200 ve for detecting recent HIV infection as the BED-CEIA and has a very low rate of false-recent misclas

201 was evaluated using 3 serologic assays: the BED capture enzyme immunoassay (CEIA), the Bio-Plex (Lum

202 No differences were observed between the BED and LC groups in the ventral striatum.

203 rho between the BED from RPT and SBRT and the percent change in PET SUV(

204 nce of different laboratories conducting the BED assay while identifying areas for improvements.

205 In contrast, the BED group relative to the OB group demonstrated diminish

206 th 0.85); and for persons within 90 days the BED (0.86).

207 LS-EIA (</=0.2 cutoff), 88% and 72% for the BED (</=0.2 cutoff), and 43%-58% and 98% (</=3 bands) fo

208 For the BED CEIA and Luminex assay, linear mixed effects models

209 of unlabeled antibody (cold protein) in the BED analysis were explored.

210 capable of analyzing data represented in the BED format.

211 it for manipulating genomic intervals in the BED format.

212 The MAAs that were evaluated included the BED-CEIA, the Bio-Rad Avidity assay, viral load, and the

213 hm (MAA) for HIV incidence that includes the BED capture enzyme immunoassay (BED-CEIA), an antibody a

214 ly identified a robust MAA that includes the BED capture enzyme immunoassay (BED-CEIA), the Bio-Rad A

215 tinct locations on domain 1 of ICAM-3 on the BED face (Asn23 and Ser25) and on the C strand or CD loo

216 molecule over a hydrophobic interface on the BED sheet of domain 1, in agreement with dimerization of

217 Thus, the BED-specific PT program enabled us to track performance

218 to compare the performance of the MAA to the BED-CEIA and to determine the window period of the MAA.

219 STARHS methodology uses the BED HIV-1 capture enzyme immunoassay to determine recent

220 f 6864 diagnostic specimens tested using the BED assay, 2133 (31%) were classified as recent infectio

221 HIV infection as recently infected using the BED-CEIA, thereby influencing a falsely high value for c

222 Samples were tested with the BED capture enzyme immunoassay (BED-CEIA) which measures

223 uring 2006 in 22 states were tested with the BED HIV-1 capture enzyme immunoassay to classify infecti

224 track needs to be cross-referenced with the BED track to identify sequences of motif hits.

225 nting or treating traits influenced by these BED-specific familial factors could reduce the public he

226 Furthermore, these BED-specific familial factors may independently increase

227 s in quality of life, and, at the same time, BED often goes undetected and untreated.

228 2% of patients with BN migrated to AN, 5% to BED, and 19% to OSFED; 9% of patients with BED migrated

229 1, n=383; study 2, n=390) meeting DSM-IV-TR BED criteria were randomized (1:1) to placebo or LDX (50

230 ROC+BWL could be an alternate model to treat BED among veterans, but effects on weight need further r

231 Tumor BED optimization results were calculated and plotted as

232 eptide amount and activity for maximal tumor BED, considering the additional constraint of a red marr

233 that would deliver 95% of the maximum tumor BED, allowing for informed inclusion of clinical conside

234 rovide insights into the genetics underlying BED and suggest directions for future translational rese

235 nding of the molecular mechanisms underlying BED-NLR-mediated resistance to various pathogens.

236 ivalent uniform dose, and equivalent uniform BED for 28 treatments (89 lesions).

237 ing the ability to submit fuzzy sets, upload BED files, improved application programming interface an

238 ipDMR uses BED format files as input and is easy to use.

239 ific Islander (API) service members, whereas BED was less likely among Black and API participants com

240 However, it remains unclear whether BED represents an etiologically distinct behavioral phen

241 at analyses included 259 and 255 adults with BED, respectively.

242 lternative compared with CBT for adults with BED.

243 sing 822 cases of individuals diagnosed with BED) to estimate the probability of each individual havi

244 The cloning of Pm6Sl, a resistance gene with BED-NLR architecture, will increase our understanding of

245 d symptoms among overweight individuals with BED.

246 N=141 patients with BED (83.7% women, mean age 43.6, mean BMI 38.6 kg/m(2))

247 gs preceding LOC eating in two patients with BED and severe obesity (trial registration no.

248 Patients with BED display an addiction-like symptomatology and the dop

249 o BED, and 19% to OSFED; 9% of patients with BED migrated to BN and 19% to OSFED; 7% of patients with

250 sed self-help intervention for patients with BED, the findings confirmed its effectiveness in reducin

251 es examining sleep outcomes in patients with BED, which collectively point to a heightened incidence

252 line treatment option for most patients with BED, with IPT (or full cognitive behavior therapy) used

253 tions in binge eating in obese patients with BED.

254 or the treatment of overweight patients with BED.

255 People with BED experience considerable burden and impairments in qu

256 ontrol and emotion regulation in people with BED, and these neurobiological domains are targets for e

257 Furthermore, relatives of probands with BED displayed a markedly higher prevalence of severe obe

258 lts were more pronounced among veterans with BED.

259 Obese subjects with and without BED did not differ from healthy volunteers but when comp

260 sorders of natural (obesity with and without BED) and drug rewards (AUD).

261 y equal magnitude for women with and without BED.

262 s observed in obese subjects with or without BED.

263 rs but not in obese subjects with or without BED.

264 ex >/=40) than relatives of probands without BED even when controlling for proband body mass index (o

265 8) and age- and weight-matched women without BED (n = 32) monitored their dietary intake and concurre

266 Zinc finger (Zf)-BED proteins are a novel superfamily of transcription fa

267 e current study identified a total of 750 Zf-BED-encoding genes in 35 land plant species including mo

268 sistance protein with a NAM domain and a ZnF-BED domain.

269 -BED module formed by a zinc finger BED (Znf-BED) domain integrated into the coiled-coil (CC) domain.